|
1
|
Finlay IG and McArdle CS: Effect of occult
hepatic metastases on survival after curative resection for
colorectal carcinoma. Gastroenterology. 85:596–599. 1983.PubMed/NCBI
|
|
2
|
Kemp Z, Thirlwell C, Sieber O, Silver A
and Tomlinson I: An update on the genetics of colorectal cancer.
Hum Mol Genet. 13(Suppl 2): R177–R185. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Konishi M, Kikuchi-Yanoshita R, Tanaka K,
Muraoka M, Onda A, Okumura Y, Kishi N, Iwama T, Mori T, Koike M, et
al: Molecular nature of colon tumors in hereditary nonpolyposis
colon cancer, familial polyposis, and sporadic colon cancer.
Gastroenterology. 111:307–317. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
van Erning FN, Crolla RM, Rutten HJ,
Beerepoot LV, van Krieken JH and Lemmens VE: No change in lymph
node positivity rate despite increased lymph node yield and
improved survival in colon cancer. Eur J Cancer. 50:3221–3229.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mazet F, Yu JK, Liberles DA, Holland LZ
and Shimeld SM: Phylogenetic relationships of the Fox (Forkhead)
gene family in the Bilateria. Gene. 316:79–89. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bieller A, Pasche B, Frank S, Gläser B,
Kunz J, Witt K and Zoll B: Isolation and characterization of the
human forkhead gene FOXQ1. DNA Cell Biol. 20:555–561. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ackermann S, Kocak H, Hero B, Ehemann V,
Kahlert Y, Oberthuer A, Roels F, Theißen J, Odenthal M, Berthold F,
et al: FOXP1 inhibits cell growth and attenuates tumorigenicity of
neuroblastoma. BMC Cancer. 14:8402014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Stoll SW, Stuart PE, Swindell WR, Tsoi LC,
Li B, Gandarillas A, Lambert S, Johnston A, Nair RP and Elder JT:
The EGF receptor ligand amphiregulin controls cell division via
FoxM1. Oncogene. 35:2075–2086. 2016. View Article : Google Scholar
|
|
9
|
Dai B, Gong A, Jing Z, Aldape KD, Kang SH,
Sawaya R and Huang S: Forkhead box M1 is regulated by heat shock
factor 1 and promotes glioma cells survival under heat shock
stress. J Biol Chem. 288:1634–1642. 2013. View Article : Google Scholar :
|
|
10
|
Kikuchi K, Hettmer S, Aslam MI, Michalek
JE, Laub W, Wilky BA, Loeb DM, Rubin BP, Wagers AJ and Keller C:
Cell-cycle dependent expression of a translocation-mediated fusion
oncogene mediates checkpoint adaptation in rhabdomyosarcoma. PLoS
Genet. 10:e10041072014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Burgering BM: A brief introduction to
FOXOlogy. Oncogene. 27:2258–2262. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ouyang W, Beckett O, Flavell RA and Li MO:
An essential role of the Forkhead-box transcription factor Foxo1 in
control of T cell homeostasis and tolerance. Immunity. 30:358–371.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schimmel J, Eifler K, Sigurðsson JO,
Cuijpers SA, Hendriks IA, Verlaan-de Vries M, Kelstrup CD,
Francavilla C, Medema RH, Olsen JV, et al: Uncovering SUMOylation
dynamics during cell-cycle progression reveals FoxM1 as a key
mitotic SUMO target protein. Mol Cell. 53:1053–1066. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Crose LE, Galindo KA, Kephart JG, Chen C,
Fitamant J, Bardeesy N, Bentley RC, Galindo RL, Chi JT and Linardic
CM: Alveolar rhabdomyosarcoma-associated PAX3-FOXO1 promotes
tumorigenesis via Hippo pathway suppression. J Clin Invest.
124:285–296. 2014. View
Article : Google Scholar
|
|
15
|
Nucera C, Eeckhoute J, Finn S, Carroll JS,
Ligon AH, Priolo C, Fadda G, Toner M, Sheils O, Attard M, et al:
FOXA1 is a potential oncogene in anaplastic thyroid carcinoma. Clin
Cancer Res. 15:3680–3689. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xia L, Huang W, Tian D, Zhang L, Qi X,
Chen Z, Shang X, Nie Y and Wu K: Forkhead box Q1 promotes
hepatocellular carcinoma metastasis by transactivating ZEB2 and
VersicanV1 expression. Hepatology. 59:958–973. 2014. View Article : Google Scholar
|
|
17
|
Wang Z, Banerjee S, Kong D, Li Y and
Sarkar FH: Downregulation of Forkhead Box M1 transcription factor
leads to the inhibition of invasion and angiogenesis of pancreatic
cancer cells. Cancer Res. 67:8293–8300. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cui YM, Jiao HL, Ye YP, Chen CM, Wang JX,
Tang N, Li TT, Lin J, Qi L, Wu P, et al: FOXC2 promotes colorectal
cancer metastasis by directly targeting MET. Oncogene.
34:4379–4390. 2015. View Article : Google Scholar
|
|
19
|
Li D, Mei H, Qi M, Yang D, Zhao X, Xiang
X, Pu J, Huang K, Zheng L and Tong Q: FOXD3 is a novel tumor
suppressor that affects growth, invasion, metastasis and
angiogenesis of neuroblastoma. Oncotarget. 4:2021–2044. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang Y, Zhang S, Wang X, Liu J, Yang L,
He S, Chen L and Huang J: Prognostic significance of FOXP1 as an
oncogene in hepatocellular carcinoma. J Clin Pathol. 65:528–533.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ko YS, Cho SJ, Park J, Kim Y, Choi YJ, Pyo
JS, Jang BG, Park JW, Kim WH and Lee BL: Loss of FOXO1 promotes
gastric tumour growth and metastasis through upregulation of human
epidermal growth factor receptor 2/neu expression. Br J Cancer.
113:1186–1196. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yan X, Zhou H and Zhang T, Xu P, Zhang S,
Huang W, Yang L, Gu X, Ni R and Zhang T: Downregulation of FOXP2
promoter human hepatocellular carcinoma cell invasion. Tumour Biol.
36:9611–9619. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huang JT and Lee V: Identification and
characterization of a novel human FOXK1 gene in silico. Int J
Oncol. 25:751–757. 2004.PubMed/NCBI
|
|
24
|
Wang W, Li X, Lee M, Jun S, Aziz KE, Feng
L, Tran MK, Li N, McCrea PD, Park JI, et al: FOXKs promote
Wnt/β-catenin signaling by translocating DVL into the nucleus. Dev
Cell. 32:707–718. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang J, Yang Y, Xia HH, Gu Q, Lin MC,
Jiang B, Peng Y, Li G, An X, Zhang Y, et al: Suppression of FHL2
expression induces cell differentiation and inhibits gastric and
colon carcinogenesis. Gastroenterology. 132:1066–1076. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tu SP, Liston P, Cui JT, Lin MC, Jiang XH,
Yang Y, Gu Q, Jiang SH, Lum CT, Kung HF, et al: Restoration of XAF1
expression induces apoptosis and inhibits tumor growth in gastric
cancer. Int J Cancer. 125:688–697. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cheng Y, Geng H, Cheng SH, Liang P, Bai Y,
Li J, Srivastava G, Ng MH, Fukagawa T, Wu X, et al: KRAB zinc
finger protein ZNF382 is a proapoptotic tumor suppressor that
represses multiple oncogenes and is commonly silenced in multiple
carcinomas. Cancer Res. 70:6516–6526. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Biggs WH III, Cavenee WK and Arden KC:
Identification and characterization of members of the FKHR (FOX O)
subclass of winged-helix transcription factors in the mouse. Mamm
Genome. 12:416–425. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lalmansingh AS, Karmakar S, Jin Y and
Nagaich AK: Multiple modes of chromatin remodeling by Forkhead box
proteins. Biochim Biophys Acta. 1819:707–715. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Badve S, Turbin D, Thorat MA, Morimiya A,
Nielsen TO, Perou CM, Dunn S, Huntsman DG and Nakshatri H: FOXA1
expression in breast cancer - correlation with luminal subtype A
and survival. Clin Cancer Res. 13:4415–4421. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Reddy OL, Cates JM, Gellert LL, Crist HS,
Yang Z, Yamashita H, Taylor JA III, Smith JA Jr, Chang SS, Cookson
MS, et al: Loss of FOXA1 drives sexually dimorphic changes in
urothelial differentiation and is an independent predictor of poor
prognosis in bladder cancer. Am J Pathol. 185:1385–1395. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
McMullin RP, Dobi A, Mutton LN, Orosz A,
Maheshwari S, Shashikant CS and Bieberich CJ: A FOXA1-binding
enhancer regulates Hoxb13 expression in the prostate gland. Proc
Natl Acad Sci USA. 107:98–103. 2010. View Article : Google Scholar :
|
|
33
|
Song Y, Washington MK and Crawford HC:
Loss of FOXA1/2 is essential for the epithelial-to-mesenchymal
transition in pancreatic cancer. Cancer Res. 70:2115–2125. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wu Y, Guo Z, Zhang D, Zhang W, Yan Q, Shi
X, Zhang M, Zhao Y, Zhang Y, Jiang B, et al: A novel colon cancer
gene therapy using rAAV-mediated expression of human shRNA-FHL2.
Int J Oncol. 43:1618–1626. 2013.PubMed/NCBI
|
|
35
|
Li X, Kong X, Kong X, Wang Y, Yan S and
Yang Q: 53BP1 sensitizes breast cancer cells to 5-fluorouracil.
PLoS One. 8:e749282013. View Article : Google Scholar : PubMed/NCBI
|
